University of Rochester Medical Center
SearchDirectoryNewsEventsStrong HealthURMC Home

Images below require Macromedia's Flash Player to view

View Other Brain Tumor Cases Next Case

Neuroradiology Case of the Week

Case 446

October 2009

Shawn Rosen, Balasubramanya Kolar, MD, and P-L Westesson, MD, PhD, DDS

Clinical Presentation: Patient is a 43-year old male, two years status post-resection of a bi-frontal esthesioneuroblastoma with adjuvant radiotherapy and chemotherapy, now presenting with increasing unsteadiness and nausea. One year ago, he underwent radiotherapy for a lumbosacral leptomeningeal mass.

Imaging Findings: See below.

Figures 1A & 1B: Prior to treatment In 2006: Axial and coronal T1-weighted images with gadolinium contrast show tumor in the nasal cavity extending into the paranasal sinuses and frontal cortex.

Figures 2A & 2B: Prior to treatment In 2006: Axial T2 and post-contrast T1-weighted images show enhancing mass within left frontal region causing effacement of the left lateral ventricle.

Figures 3A & 3B: Metastases in 2008: Axial T1-weighted images with gadolinium contrast show bilateral cerebellomedullary and cerebellopontine enhancing lesions extending along the VII -VIII nerve complex and XII nerves.
Figures 4A & 4B: Metastases in 2008: Axial T1-weighted images with gadolinium contrast show lesion extension to bilateral subependymal surfaces in the lateral ventricles, pituitary stalk and in the left medial temporal lobe.

Diagnosis: Recurrent esthesioneuroblastoma

Discussion: Esthesioneuroblastoma is a rare malignancy arising from the olfactory epithelium. First reported by Berger in 1924, 945 cases have been reported with half in the last decade [1]. The first staging system was proposed by Kadish in 1976 trifurcates disease into three stages: A – confined to the nasal cavity; B – confined to the nasal cavity and one or more paranasal sinuses; and C – extending beyond that in B, including involvement of the orbit, base of skull or intracranial cavity, cervical lymph nodes, or distant metastatic sites. This staging system has been found to be of prognostic significance, with reoccurrence rates of 20%, 56%, and 78% for patients with stage A, B, and C disease, respectively [1]. While the condition can respond favorably to therapy, at least one recent case report described a patient with subdural metastases who deteriorated within two years of the metastases’ identification [1].
     One distinguishing feature of esthesioneuroblastomas are their occasional focal calcifications, which makes CT particularly useful in the presence of a superior nasal mass. Although esthesioneuroblastomas are initially unilateral within the upper nasal cavity, they subsequently expand the nasal cavity and ethmoid air cells bilaterally, before penetrating the orbit and cribriform plate. There is a broad base of bony destruction when the tumor extends into the anterior cranial fossa [2].
     Imaging can be especially important in making the diagnosis as the histopathologic diagnosis can be difficult, mistaking the tumor for other anterior cranial fossa tumors including lymphoma, meningioma, and squamous cell carcinoma [2].

References:

  1. Capelle L, Krawitz H. Esthesioneuroblastoma: A case report of diffuse subdural recurrence and review of recently published studies. J Med Imaging Radiat Oncol. 2008 Feb;52(1):85-90. PMID: 18373833 [PubMed]
  2. Connor SE, Umaria N, Chavda SV. Imaging of giant tumours involving the anterior skull base. Br J Radiol. 2001 Jul;74(883):662-7. PMID: 11509406 [PubMed]
View Other Brain Tumor Cases Next Case